Minova Life Science

Minova life sciences - Pharmaceutical company

Escitrac-CZ Tablets

COMPOSITION – Escitalopram 10mg, Clonazepam  IP  0.5mg


Escitalopram + Clonazepam 



• Demonstrates 74.1% efficacy with a good safety profile in patients with depression with therapy for 8 weeks!

• Demonstrates more effective & cost-saving therapy in the treatment of major depressive disorder in comparison to venlafaxine XR therapy


•Demonstrates a high efficacy in the treatment of depression due to its longer half life & easier for discontinuation due to its minimal withdrawal symptoms in comparison to other anti-depressive agents

• Effective therapy for the augmentation of ongoing antidepressant treatment in prolonged depressive patients with suboptimal improvement

Explore other products

Scroll to Top